Marcus Ruscetti

17PUBLICATIONS
88CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyHaematological tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 21, 2026
Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer.

|Jun 19, 2026
Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer.

|Mar 26, 2026
Tumor Homing Nanoparticle Immunotherapy for Acute Clearance and Mitigation of T-cell Exhaustion in Humanized High-Risk Neuroblastoma.

Griffin I Kane, Miranda B Diaz-Infante, Kim Wigglesworth

|Dec 09, 2025
Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression.

Suresh Chava, Suresh Bugide, Parmanand Malvi

|Oct 24, 2025
p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy.

Lin Zhou, Kelly D DeMarco, Katherine C Murphy

|Sep 22, 2025
PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumors.

Shreya R Chowdhury, Chaitanya N Parikh, Arshia N Kaur

Pageof 3

Frequent Collaborators

8 joint publications

Lihua Julie Zhu

8 joint publications

Katherine C Murphy

5 joint publications

Kelly D DeMarco

5 joint publications

Lin Zhou